YM178

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for YM178, covering 2013-06-12 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of YM178 in Patients With Symptomatic Overactive Bladder [Phase 2]